Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis - PubMed (original) (raw)
Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis
Toni Ahtoniemi et al. Mol Pharmacol. 2007 Jan.
Abstract
Pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear transcription factor kappa-B (NF-kappaB) and an antioxidant, has beneficial effects in animal models of various diseases, including arthritis, brain ischemia, spinal cord injury, Alzheimer's disease, and Duchenne muscular dystrophy. Because inflammation and oxidative damage are also hallmarks of amyotrophic lateral sclerosis (ALS), we studied the effect of oral PDTC treatment on G93A-superoxide dismutase 1 (SOD1) transgenic (TG) rat model of human ALS and observed that PDTC treatment significantly decreases the survival. PDTC treatment evoked the end stage of the disease at 121 +/- 21 days, whereas untreated TG animals reached the end stage at 141 +/- 13 days (p < 0.01). The DNA binding activity of NF-kappaB was not altered in G93A-SOD1 TG rats by PDTC treatment. The copper concentration in the spinal cord was increased after PDTC treatment both in G93A-SOD1 TG and wild-type rats, suggesting that increased copper may enhance the neurotoxicity of mutant SOD1. The amount of ubiquitinated proteins were significantly higher and proteasomal activity was decreased in the spinal cords of PDTC-treated TG rats compared with other groups, suggesting that PDTC treatment decreases proteasome function. Immunoblotting and immunocytochemistry showed that the level of immunoproteasome but not constitutive proteasome was increased in glia of G93A-SOD1 TG rats along with disease development. PDTC treatment completely blocked the induction of immunoproteasome expression without affecting constitutive proteasome. These results suggest that PDTC acts as an immunoproteasome inhibitor in mutant SOD1 rats and that immunoproteasome may help the nervous system to cope with deleterious effects of SOD1-G93A mutation.
Similar articles
- Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats.
La Rosa G, Cardali S, Genovese T, Conti A, Di Paola R, La Torre D, Cacciola F, Cuzzocrea S. La Rosa G, et al. J Neurosurg Spine. 2004 Oct;1(3):311-21. doi: 10.3171/spi.2004.1.3.0311. J Neurosurg Spine. 2004. PMID: 15478370 - Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury.
Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson RW, Rotstein OD. Nathens AB, et al. Am J Respir Cell Mol Biol. 1997 Nov;17(5):608-16. doi: 10.1165/ajrcmb.17.5.2661. Am J Respir Cell Mol Biol. 1997. PMID: 9374112 - Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. Howland DS, et al. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1604-9. doi: 10.1073/pnas.032539299. Epub 2002 Jan 29. Proc Natl Acad Sci U S A. 2002. PMID: 11818550 Free PMC article.
Cited by
- Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress.
Höhn A, Tramutola A, Cascella R. Höhn A, et al. Oxid Med Cell Longev. 2020 Mar 27;2020:5497046. doi: 10.1155/2020/5497046. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32308803 Free PMC article. Review. - Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.
Trojsi F, Monsurrò MR, Tedeschi G. Trojsi F, et al. Int J Mol Sci. 2013 Jul 24;14(8):15286-311. doi: 10.3390/ijms140815286. Int J Mol Sci. 2013. PMID: 23887652 Free PMC article. Review. - Ubiquitin-Proteasome System in Neurodegenerative Disorders.
Rao G, Croft B, Teng C, Awasthi V. Rao G, et al. J Drug Metab Toxicol. 2015;6(4):187. doi: 10.4172/2157-7609.1000187. Epub 2015 Aug 13. J Drug Metab Toxicol. 2015. PMID: 30761219 Free PMC article. - Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
Momtaz S, Memariani Z, El-Senduny FF, Sanadgol N, Golab F, Katebi M, Abdolghaffari AH, Farzaei MH, Abdollahi M. Momtaz S, et al. Front Physiol. 2020 Apr 28;11:361. doi: 10.3389/fphys.2020.00361. eCollection 2020. Front Physiol. 2020. PMID: 32411012 Free PMC article. - Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review.
Sheykhansari S, Kozielski K, Bill J, Sitti M, Gemmati D, Zamboni P, Singh AV. Sheykhansari S, et al. Cell Death Dis. 2018 Mar 1;9(3):348. doi: 10.1038/s41419-018-0379-2. Cell Death Dis. 2018. PMID: 29497049 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous